1. Home
  2. EIG vs SION Comparison

EIG vs SION Comparison

Compare EIG & SION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EIG
  • SION
  • Stock Information
  • Founded
  • EIG 2000
  • SION 2019
  • Country
  • EIG United States
  • SION United States
  • Employees
  • EIG N/A
  • SION N/A
  • Industry
  • EIG Property-Casualty Insurers
  • SION
  • Sector
  • EIG Finance
  • SION
  • Exchange
  • EIG Nasdaq
  • SION NYSE
  • Market Cap
  • EIG 1.1B
  • SION 920.2M
  • IPO Year
  • EIG 2007
  • SION 2025
  • Fundamental
  • Price
  • EIG $46.22
  • SION $20.47
  • Analyst Decision
  • EIG Strong Buy
  • SION Strong Buy
  • Analyst Count
  • EIG 1
  • SION 1
  • Target Price
  • EIG $58.00
  • SION $32.00
  • AVG Volume (30 Days)
  • EIG 173.2K
  • SION 260.6K
  • Earning Date
  • EIG 07-30-2025
  • SION 08-25-2025
  • Dividend Yield
  • EIG 2.77%
  • SION N/A
  • EPS Growth
  • EIG N/A
  • SION N/A
  • EPS
  • EIG 4.13
  • SION N/A
  • Revenue
  • EIG $860,200,000.00
  • SION N/A
  • Revenue This Year
  • EIG N/A
  • SION N/A
  • Revenue Next Year
  • EIG $3.61
  • SION N/A
  • P/E Ratio
  • EIG $11.20
  • SION N/A
  • Revenue Growth
  • EIG N/A
  • SION N/A
  • 52 Week Low
  • EIG $42.82
  • SION $7.26
  • 52 Week High
  • EIG $54.44
  • SION $25.19
  • Technical
  • Relative Strength Index (RSI)
  • EIG 41.73
  • SION N/A
  • Support Level
  • EIG $46.43
  • SION N/A
  • Resistance Level
  • EIG $47.91
  • SION N/A
  • Average True Range (ATR)
  • EIG 0.78
  • SION 0.00
  • MACD
  • EIG -0.02
  • SION 0.00
  • Stochastic Oscillator
  • EIG 15.69
  • SION 0.00

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

Share on Social Networks: